The Medical Device Excise Tax—Over Before It Begins? (Reply)

In this exchange, industry representatives challeng the authors’ analysis of the ACA’s 2.3% medical device excise tax, claiming it has already caused job losses, reduced R&D spending, and will not generate the predicted revenue benefits. The authors reply that they remain skeptical of industry’s anecdotal claims, note that imaging utilization data from Massachusetts do not support the critics’ conclusions due to confounding factors.